Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation.

Autor: Alvarenga, Elenice M.1, Souza, Luan K.M.1, Araújo, Thiago S.L.1, Nogueira, Kerolayne M.1, Sousa, Francisca Beatriz M.1, Araújo, Alyne R.2, Martins, Conceição S.3, Pacífico, Dvison M.3, de C. Brito, Gerly Anne3, Souza, Emmanuel P.3, Sousa, Damião P.4, Medeiros, Jand Venes R.1 jandvenes@ufpi.edu.br
Zdroj: Chemico-Biological Interactions. Dec2016, Vol. 260, p129-140. 12p.
Databáze: Academic Search Ultimate
Externí odkaz: